Skip to content

Drug interactions

Basiliximab + Canakinumab

Severity: Major

Basiliximab and Canakinumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Canakinumab blocks IL-1 beta and is associated with serious infections. With basiliximab, overall immunosuppression and infection risk may be increased.

What this interaction means in plain words

Basiliximab and Canakinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Basiliximab belongs to Miscellaneous; Canakinumab belongs to Miscellaneous.

Evidence level: Low

Why it happens

Additive immunosuppression through IL-1 beta neutralization and IL-2 receptor blockade.

What to do

Avoid combining where possible; if both are needed, monitor closely for infection and withhold canakinumab during serious infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Basiliximab and Canakinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Basiliximab with Canakinumab?

MediHelp rates the interaction as major. Basiliximab and Canakinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Canakinumab blocks IL-1 beta and is associated with serious infections. With basiliximab, overall immunosuppression and infection risk may be increased.

How serious is the interaction between Basiliximab and Canakinumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible; if both are needed, monitor closely for infection and withhold canakinumab during serious infection.

What other medicines interact with Basiliximab?

MediHelp also lists interactions of Basiliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Basiliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in